Search results
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
Digital Journal· 12 hours ago...initiation, enrollment and maintenance of patients, and the completion of clinical trials, the availability and timing of data from ongoing clinical trials, the trial design includes combination therapies that may make it difficult to accurately ascertain the benefits of APVO436, expectations...
Is This a Setback for Moderna?
Motley Fool via Yahoo Finance· 14 hours agoBut there's room for more than one, and Moderna may even excel thanks to a couple of factors. The biotech's candidate wasn't linked to any cases of...
1 No-Brainer Growth Stock to Buy and Hold
The Motley Fool via AOL· 3 days agoAt the very least, it indicates that the FDA likely has concerns regarding Eli Lilly's application -- specifically, the design of the clinical trial it ...
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York...
The Joplin Globe· 5 days agoSHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R.
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 2 days agoAnd, at a time when its coronavirus vaccine revenue is no longer enough to make the stock as...
Lula’s progress plan for Brazil: A year on
Pharmaceutical Technology via Yahoo Finance· 2 days agoStill he says the handling of the coronavirus in Brazil demonstrated its control was only possible due to technology transfer negotiations among national...
AstraZeneca withdraws Covid-19 vaccine, citing low demand
CNN Business via AOL· 6 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 day agoPositive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b study evaluating Vaxart
Mers outbreak in Saudi Arabia puts health experts on high alert
The Telegraph via Yahoo News· 4 days agoHealth agencies are racing to determine the origins of a Mers outbreak in Saudi Arabia, after three...
AstraZeneca Is Withdrawing Its Covid Vaccine Worldwide, Citing Low Demand
New York Times· 6 days agoThe shot is no longer being manufactured or supplied, and it is no longer authorized for use in...
